Zydus Cadila receives tentative approval from US FDA for Pimavanserin capsules
Pimavanserin is an atypical antipsychotic and is indicated for the treatment of hallucinations and delusions associated with…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Zydus Cadila
Zydus Cadila receives tentative approval from US FDA for Pimavanserin tablets
The tablets are used to treat the symptoms of a certain mental/mood disorder (psychosis) that might occur with Parkinson's disease
Zydus receives Orphan Drug Designation from US FDA for malaria treatment
The Orphan Drug Designation provides up to seven years of marketing exclusivity in the US
Zydus Cadila Desidustat’s better positioned to get first-to-market advantage within HIF-PHI…
Zydus Cadila has recently filed desidustat in India based on Dream-ND (588 patients) and Dream-D (392 patients) phase-III trials'…
Zydus to begin phase-II (a) clinical trial of oral inflammasome inhibitor in patients with…
Cryopyrin-Associated Periodic Syndrome (CAPS) is a rare life-long auto-inflammatory condition, caused by NLRP3 activating…
Zydus Cadila receives tentative approval from US FDA for Cariprazine Capsule
Zydus’s Cariprazine Capsules are indicated for the treatment of schizophrenia and acute treatment of manic or mixed episodes…
Zydus develops new treatment for patients suffering from Chronic Kidney Disease (CKD)
The company submits first New Drug Application (NDA) to DCGI
Zydus Cadila receives final approval from US FDA for Decitabine injection
Decitabine is used to treat myelodysplastic syndromes, certain types of blood or bone marrow cancer